María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
Chinese University of Hong Kong
Sha Tin, Hong KongPublicaciones en colaboración con investigadores/as de Chinese University of Hong Kong (2)
2021
-
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design
Future Oncology, Vol. 17, Núm. 12, pp. 1459-1472
2020
-
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
The Lancet Oncology, Vol. 21, Núm. 2, pp. 271-282